1. Dysregulated ceramides metabolism via PTPN11 exposes a metabolic vulnerability to breast cancer metastasis
   Sen Qiao et al, 2023, Medical Oncology CrossRef
2. Puerarin Decreases the Expression of FUS‐Dependent MAPK4 to Inhibit the Development of Triple‐Negative Breast Cancer
   Jian Guo et al, 2024, Chemical Biology & Drug Design CrossRef
3. MYC/NBS1-Mediated DNA Damage Response is Involved in the Inhibitory Effect of Hydroxysafflor Yellow A on Glioma Cells
   Dongfang Tang et al, 2021, Drug Design, Development and Therapy CrossRef
4. Bioinformatics, Molecular Docking and Experiments In Vitro Analyze the Prognostic Value of CXC Chemokines in Breast Cancer
   Fei Wang et al, 2021, Frontiers in Oncology CrossRef
5. Exploring the mechanism and experimental verification of puerarin in the treatment of endometrial carcinoma based on network pharmacology and bioinformatics analysis
   Zhiheng Lin et al, 2022, BMC Complementary Medicine and Therapies CrossRef
6. Study on conversion of microstates in breast cell ensemble at the gene level based on the eigen-microstate method
   Su-Hua Zhang et al, 2023, Chinese Physics B CrossRef